Product
FB704A
Aliases
FB704A placebo
1 clinical trial
1 indication
Indication
AsthmaClinical trial
A Randomized, Placebo Controlled, Double Blind Phase IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Clinical Activity of Multiple Intravenous Doses of FB704A in Adults With Severe AsthmaStatus: Recruiting, Estimated PCD: 2025-09-30